Trial Profile
Addition of Dexmedetomidine to Ropivacaine-induced Supraclavicular Plexus Block, a Randomized Controlled Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 May 2017
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Ropivacaine
- Indications Pain; Sedation
- Focus Therapeutic Use
- Acronyms ADRIB
- 10 Aug 2016 Status changed from recruiting to completed.
- 26 Dec 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
- 18 Dec 2015 New trial record